Evidence map›Paper›PMID 42169207›Full record

ArticleZoonoses and public health2026

Barriers to Canine Rabies Vaccination in Nigeria: Implications for Rabies Elimination by 2030.

Philip P Mshelbwala, Bura T Paul, Emmanuel O Njoga, Solomon W Audu, Musundwa Mugodi, Precious I Okezie, Kinley Wangdi, Claude T Sabeta, Charles E Rupprecht

Abstract read
In one paragraph

Article in Zoonoses and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Philip P MshelbwalaDepartment of Primary Industries and Regional Development, Orange, New South Wales, Australia.ORCID https://orcid.org/0000-0002-6834-1456
Bura T PaulUniversiti Putra Malaysia Sarawak, Bintulu, Malaysia.ORCID https://orcid.org/0000-0003-0110-8411
Emmanuel O NjogaUniversity of Nigeria, Nsukka, Nigeria.
Solomon W AuduAhmadu Bello University, Zaria, Nigeria.
Musundwa MugodiDepartment of Veterinary Tropical Diseases, Faculty of Veterinary, University of Pretoria, Pretoria, South Africa.
Precious I OkezieMichael Okpara University of Agriculture, Umudike, Nigeria.
Kinley WangdiHEAL Global Research Centre, Health Research Institute, Faculty of Health, University of Canberra, Bruce, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0002-8857-2665
Claude T SabetaDepartment of Veterinary Tropical Diseases, Faculty of Veterinary, University of Pretoria, Pretoria, South Africa.ORCID https://orcid.org/0000-0001-7842-7985
Charles E RupprechtCollege of Forestry, Wildlife and Environment, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA.ORCID https://orcid.org/0000-0002-8010-0743

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMass dog rabies vaccination is the most effective strategy for preventing human rabies and interrupting transmission. However, achieving high vaccination coverage in dog populations remains challenging in many low- and middle-income countries (LMICs), due to multiple barriers. In Nigeria, Africa's most populous country, rabies remains a major public health burden, with domestic dogs as the primary reservoir. Efforts to scale up canine rabies vaccination are limited by the lack of a coordinated national programme and challenges related to affordability, service availability, infrastructure, and owner awareness.

methodsWe conducted a cross-sectional study of dog-owning households in three Nigerian states and the Federal Capital Territory (FCT) and developed a probabilistic model to uncover contextual factors associated with perceived barriers to canine rabies vaccination among owners of unvaccinated dogs.

resultsPosterior distributions of our model estimates indicate that respondents reporting not knowing how to vaccinate their dogs against rabies were more likely to have tertiary education, prior awareness of rabies, use dogs for security purposes, urban residence, and residence in areas with higher household poverty. In contrast, respondents reporting knowledge of rabies transmission via bites from rabid dogs, access to local veterinary services, good road networks, and ownership of partially confined dogs were less likely to perceive this barrier. Respondents who were students, had attained tertiary education, resided in urban areas, and were in the FCT and Anambra State were more likely to perceive the rabies vaccine as too costly. Conversely, respondents from medium-sized households, those who relied on traditional care in the event of a dog bite, and owners of partially confined dogs were also more likely to perceive the rabies vaccine as too costly. Finally, respondents who had heard about rabies and those with tertiary education were less likely to perceive the rabies vaccine as unimportant.

conclusionsOur study identified key barriers to canine rabies vaccination in Nigeria, including lack of knowledge, perceived high cost, and low perceived importance. These were influenced by socioeconomic factors, place of residence, and dog ownership practices, while rabies awareness, veterinary access, good road infrastructure, and partial confinement reduced these perceptions. These findings highlight the need for targeted, context-specific strategies to improve affordability, access, and infrastructure, particularly among disadvantaged households.

Indexed as

Dog DiseasesRabiesRabies VaccinesVaccinationAnimalsCross-Sectional StudiesDisease EradicationDogsFemaleHealth Knowledge, Attitudes, PracticeHumansNigeriaRabies VaccinesbarriereliminationNigeriaperceivedrabiesvaccination

Identifiers

PMID42169207
PMCPMC13326991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.